Unique ID issued by UMIN | UMIN000030375 |
---|---|
Receipt number | R000034677 |
Scientific Title | Clinical evaluation of intake of collagen peptides in increasing skin moisture content |
Date of disclosure of the study information | 2017/12/13 |
Last modified on | 2017/12/13 12:04:36 |
Clinical evaluation of intake of collagen peptides in increasing skin moisture content
Clinical evaluation of intake of collagen peptides in increasing skin moisture content
Clinical evaluation of intake of collagen peptides in increasing skin moisture content
Clinical evaluation of intake of collagen peptides in increasing skin moisture content
Japan |
Healthy subjects
Dermatology | Adult |
Others
NO
Confirmation of improvement skin moisture content after the consumption of a test food in healthy subjects
Efficacy
Stratum corneum water content at 0, 4, 8, 12 weeks after the intake
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
3
Prevention
Food |
Test food (1 g a day for 12 weeks)
Test food (5 g a day for 12 weeks)
Placebo food (12 weeks)
35 | years-old | <= |
50 | years-old | >= |
Female
A person who is a healthy person who does not fall under the following exclusion criteria and whose age at the time of consent acquisition date is from 35 years old to under 50 years old and who give written informed consent
1) Individuals who considered that they had dry skin
2) Individual who considered that they had decreased skin elasticity
3) Individuals who agreed to abstain from drinking alcohol from the day before measurement to the end of measurement
4) Individuals who agreed to participate in the study
1) Individuals who habitually use medicines, collagen-containing supplement, skin supplement, or slimming aid
2) Individuals with skin abnormalities at the sites to be tested
3) Patients with food allergies
4) Individuals who had received cosmetic medical treatment at the sites to be tested
5) Individuals who had received facial treatment within 1 month before the start of the study
6) Individuals with chronic conditions such as atopic dermatitis
7) Patients receiving drug therapy as outpatients
8) Habitual smokers
9) Patients with asthma
10) Individuals taking or intending to take drugs for pollinosis
11) Pregnant woman, woman desiring to become pregnant, or lactating woman
12) Individuals who had participated in other studies within the previous 3 months
13) Subjects who are judged as unsuitable for the study by the investigator for other reason
90
1st name | |
Middle name | |
Last name | Masashi Ogo |
Siseido Co., Ltd.
Global Innovation Center
2-2-1, Hayabuchi, Tsuzuki-ku, Yokohama, Kanagawa, 224-8558 Japan
045-590-6000
masashi.ogo@to.shiseido.co.jp
1st name | |
Middle name | |
Last name | Kazunori Takashima |
Inforward, Inc
Ebisu Skin Research Center
1-11-2 Ebisu, Shibuya, Tokyo 1500013, Japan
03-5447-6411
takashima@inforward.co.jp
Siseido Co., Ltd.
none
Self funding
NO
2017 | Year | 12 | Month | 13 | Day |
Unpublished
Completed
2015 | Year | 11 | Month | 13 | Day |
2015 | Year | 11 | Month | 27 | Day |
2016 | Year | 05 | Month | 19 | Day |
2016 | Year | 05 | Month | 20 | Day |
2016 | Year | 11 | Month | 24 | Day |
2017 | Year | 12 | Month | 13 | Day |
2017 | Year | 12 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034677